Mundelein, IL, United States of America

Lisa Marie Frey


Average Co-Inventor Count = 8.4

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Lisa Marie Frey: Pioneering LHRH Antagonists in Pharmaceutical Innovation**

Introduction

Lisa Marie Frey, an accomplished inventor based in Mundelein, Illinois, has made significant contributions to the pharmaceutical industry with her innovative research and developments. With a total of four patents to her name, Lisa is recognized for her work in creating compounds that serve as effective LHRH antagonists, which play a crucial role in hormone modulation and therapeutic applications.

Latest Patents

Lisa's latest patents include groundbreaking research on 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives. These compounds demonstrate antagonistic activity against luteinizing hormone-releasing hormone (LHRH), illustrating their potential in treating various hormonal disorders. Additionally, her work on tetrahydroisoquinoline derivatives highlights another approach to developing LHRH antagonists, including pharmaceutical compositions and methods for their use and preparation.

Career Highlights

As an inventor at Abbott Laboratories Corporation, Lisa Marie Frey has been instrumental in advancing pharmaceutical innovations. Her extensive research not only enhances the company's portfolio but also contributes significantly to medical science and patient care. Her dedication and expertise have led her to become a recognized figure in her field.

Collaborations

Throughout her career, Lisa has collaborated with proficient colleagues, including Fortuna Haviv and Milan Bruncko. These partnerships have enabled her to combine diverse knowledge and insights, effectively pushing the boundaries of pharmaceutical research and development.

Conclusion

In conclusion, Lisa Marie Frey's inventive spirit and determination have solidified her place as a leader in pharmaceutical innovation. Her patents and collaborations reflect her commitment to advancing medical technology, providing new avenues for treatment, and ultimately improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…